Upgrade to SI Premium - Free Trial

Pfizer (PFE) Tops Q4 EPS by 1c; Reports $5B Buyback; Guides FY11, Raises FY12 Outlook

February 1, 2011 8:03 AM
Pfizer Inc. (NYSE: PFE) reported Q4 EPS of $0.47, $0.01 better than the analyst estimate of $0.46 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Hot Earnings Hot Guidance Hot List Stock Buybacks